By Josh White
Date: Monday 27 Mar 2023
(Sharecast News) - Allergy Therapeutics, a UK-based biotechnology company specialising in allergy vaccines, announced the start of the first application of its 'VLP Peanut' vaccine candidate in peanut-allergic patients on Monday.
Interim Results for six months ended 31 Dec 2023 | 27-Mar-2024 | 07:00 | RNS |
Update on funding | 27-Mar-2024 | 07:00 | RNS |
VLP Peanut PROTECT Trial Update | 12-Mar-2024 | 08:59 | RNS |
Appointment of Shaun Furlong to Board of Directors | 11-Mar-2024 | 07:00 | RNS |
Result of AGM | 08-Mar-2024 | 13:49 | RNS |
Allergy drug firm hit by trials setback | 12-Jul-2007 | The Independent |
Need to Know: Global Business Briefing | 25-Mar-2006 | Times |
FTSE Close: BP and Lloyds lead rally | 21-Sep-2010 | Daily Mail |
Tempus:Allergy Therapeutics | 22-Sep-2009 | Times |
Investment Column:Allergy Therapeutics | 22-Sep-2009 | The Independent |
Market report: Wednesday lastest | 14-May-2008 | Daily Mail |
Market Report: Prudential gains after bid specul... | 13-Mar-2008 | The Independent |
No recent information was found.
Currency | UK Pounds |
Share Price | 3.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 6.25 |
52 Week Low | 0.88 |
Volume | 120,404 |
Shares Issued | 4,766.44m |
Market Cap | £142.99m |
RiskGrade | 268 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:40 | 62 @ 2.80p |
15:40 | 997 @ 3.20p |
15:40 | 497 @ 2.80p |
15:40 | 497 @ 3.20p |
15:40 | 78 @ 2.80p |
You are here: research